We are live on
!
Find out more
Axsome Therapeutics
AXSM
AXSM
189 hedge funds and large institutions have $1.15B invested in Axsome Therapeutics in 2022 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 69 increasing their positions, 48 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 23
44% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 48
39% more capital invested
Capital invested by funds: $827M → $1.15B (+$320M)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
9% more funds holding
Funds holding: 174 → 189 (+15)
8.26% more ownership
Funds ownership: 55.5% → 63.76% (+8.3%)
0% more call options, than puts
Call options by funds: $114M | Put options by funds: $113M
Holders
189
Holders Change
+15
Holders Change %
+8.62%
% of All Funds
3.26%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
42
Increased
69
Reduced
48
Closed
23
Calls
$114M
Puts
$113M
Net Calls
+$231K
Net Calls Change
+$4.5M
